by Bernardo Garcia Finanzas Personales | 03/03/2025 03:00 AM | Blog
🚀 Rheinmetall is experiencing significant growth due to increased defense spending in Europe.
⚠️ The analyst believes the stock may be overvalued due to its recent surge.
💰 Potential for further gains exists, but the risk is high.
🧐 The analyst suggests exploring other market opportunities with less risk.
Read more!
by Bernardo Garcia Finanzas Personales | 03/03/2025 03:00 AM | NVDA
🔍 Singapore is investigating whether Dell and Supermicro servers shipped to Malaysia contained Nvidia chips prohibited in China.
🌐 The case highlights the role of intermediaries in channeling high-end semiconductors.
😲 The analyst expresses no surprise, given prior knowledge of such practices.
Read more!
by Bernardo Garcia Finanzas Personales | 03/03/2025 03:00 AM | ABBV
🚀 AbbVie is entering the competitive weight loss market by acquiring a next-generation obesity drug from Gubra.
💰 The deal involves a significant upfront payment and potential milestone payments.
💪 AbbVie aims to compete with Eli Lilly and Novo Nordisk in a market expected to reach $130 billion in annual sales by 2030.
❓ The analyst questions whether the high initial price is justified, given the crowded market.
Read more!
by Bernardo Garcia Finanzas Personales | 02/03/2025 07:00 AM | TSLA
⚠️ Tesla's stock has been declining due to various factors, including potential policy changes and production delays.
🚀 Positive catalysts include potential regulatory easing under a new Trump administration and the launch of a more affordable vehicle.
🤖 The success of Tesla's full self-driving (FSD) technology and Optimus robot program are critical for future growth.
🤔 The stock's high valuation and Elon Musk's controversies pose risks to investors.
Read more!
by Bernardo Garcia Finanzas Personales | 01/03/2025 07:00 AM | NCMI
🎬 Emerged from bankruptcy following the pandemic.
📉 Stock has been affected by writer strikes.
⬆️ Riverwater believes National CineMedia can recover approximately $105 million in EBITDA with the recovery of the box office.
💰 Currently trading at five times enterprise value over EBITDA.
Read more!